Work

Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation

Year: 2024

Type: article

Abstract: and atractylodin activated the AMPK signaling pathway, leading to improvements in HFD-induced obesity, fatty liver, and glucose intolerance. This study suggests that the phytochemical, atractylodin, can be a treatment option for MASLD.

Source: Biomolecules & Therapeutics

DOI: 10.4062/biomolther.2024.083

Authors: Ga Yeon Song, Sun Myoung Kim, Seungil Back, Seung-Bo Yang, Yoon Mee Yang

Institutions: Kangwon National University, Gachon University

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: Ministry of Health and Welfare, Korea Basic Science Institute, National Research Foundation of Korea, Ministry of Science and ICT, South Korea

Awards: G3480180213, G429769977, G6609461736, G6680530089, G8210369889, G8813770003

OpenAlex ID: W4403339936

FWCI: 2.387

Cites: 50

Cited by: 9

Related to: 10